From: PD-L1 and CD4 are independent prognostic factors for overall survival in endometrial carcinomas
 | Mean ± SD | Min | Max | Cut-off | Category | N (%) |
---|---|---|---|---|---|---|
PD-L1 in TCs | 1.36 ± 1.47 | 0 | 9 | 0< | High expression | 155 (70) |
Low expression | 66 (30) | |||||
PD-L1 in TICs | 2.70 ± 1.94 | 0 | 9 | 4< | High expression | 36 (16) |
Low expression | 185 (84) | |||||
PD-1+ TICs | 16.94 ± 23.55 | 0 | 129.33 | 6.67< | High density | 131 (59) |
Low density | 90 (41) | |||||
VEGF in TCs | 3.64 ± 1.69 | 1 | 9 | 2< | High expression | 151 (68) |
Low expression | 70 (32) | |||||
CD4+ TICs | 137.99 ± 65.18 | 31 | 391 | 126.33< | High density | 117 (53) |
Low density | 104 (47) | |||||
CD8+ TICs | 196.52 ± 121.71 | 18.33 | 582.67 | 296.33< | High density | 43 (19) |
Low density | 178 (81) | |||||
CD68+ TICs | 161.61 ± 88.00 | 16.33 | 527.67 | 126< | High density | 129 (58) |
Low density | 92 (42) |